Raymond James & Associates »

Bellerophon Therapeutics shares owned by Raymond James & Associates

Quarter-by-quarter ownership of Bellerophon Therapeutics (BLPH) shares owned by Raymond James & Associates from 13F filings

Historical chart of Raymond James & Associates investment in Bellerophon Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Bellerophon Therapeutics held by Raymond James & Associates consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Bellerophon Therapeutics by Raymond James & Associates

Quarter filed Position value Share count Share price at filing
2023-12-31 $370 10k 0.04
2023-09-30 $4.0k 10k 0.40
2023-06-30 $7.7k 11k 0.69

More positions owned by Raymond James & Associates

Vanguard Index Fds S&p 500 Etf Shs (VOO)
Ishares Tr Core Us Aggbd Et (AGG)
Microsoft Corporation (MSFT)
Apple (AAPL)
Amazon (AMZN)
NVIDIA Corporation (NVDA)
Ishares Tr Core Msci Eafe (IEFA)
JPMorgan Chase & Co. (JPM)
Broadcom (AVGO)
Alphabet Cap Stk Cl A (GOOGL)
Home Depot (HD)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Ishares Tr Msci Usa Min Vol (USMV)
Merck & Co (MRK)
Eaton Corp SHS (ETN)

View all positions for Raymond James & Associates